Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells

The aim of our study was to determine whether the use of cisplatin in the presence echistatin in MDA-MB-231 breast cancer cells leads to a reduction of toxic effects associated with the use of cisplatin. The expression of β(1)-integrin and insulin-like growth factor 1 receptor (IGF-IR), signaling pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnomysy, Robert, Surażyński, Arkadiusz, Popławska, Bożena, Rysiak, Edyta, Pawłowska, Natalia, Czajkowska, Anna, Bielawski, Krzysztof, Bielawska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306075/
https://www.ncbi.nlm.nih.gov/pubmed/27995416
http://dx.doi.org/10.1007/s11010-016-2894-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306075/
https://www.ncbi.nlm.nih.gov/pubmed/27995416
http://dx.doi.org/10.1007/s11010-016-2894-8

Ejemplares similares